Skip to content

AHC International Media Library

Alternating Hemplegia of Childhood and ATP1A3 disorders

  • Interviews
  • Home Videos
  • News
  • Associations
  • Documentaries
  • Presentations
  • Contact
  • About AHCIM
  • Articles
  • Toggle search form

Fiorella Gurrieri at the ATP1A3 Symposium in Disease, Chicago 2018

Posted on November 24, 2018November 24, 2018 By siggi

Professor Fiorella Gurrieri tells us about an exciting new project that she is working on.

Gurrieri“s research group is doing research with cell lines that have 5 of the ATP1A3 mutations and they find that those cell lines accumulate excessive sodium.
Finding out which drug can interact with this mechanism is the project they are now working on with other groups. They already have compounds from a pharmaceutical company and are starting to screen them.
Then they will try the candidate molecules with mouse models that they get from Duke University. The key is this kind of research is collaboration. Collaboration between researchers, parents and other specialists is the key because everyone brings a unique experience and background to the table.

Interviews, News Tags:atp1a3, atp1a3 reykjavik, cell lines, collaboration, compounds, Fiorella Gurrieri, italy, molicules, mutation, reserach, reseracher

Post navigation

Previous Post: Dr. Mohamad Mikati at the ATP1A3 symposium in Chicago 2018
Next Post: Alfred George at the ATP1A3 symposium in disease, Chicago 2018

Related Posts

Vicky Lewis and Adrian Kowal – London 2016 Interviews
Dr Kenneth Silver Interviews
Dr Brashear Explains Alternating Hemiplegia of Childhood Interviews
Local girl battles rare, debilitating disease Interviews
Dr. Hendrik Rosewich – Assistant Professor Interviews
AHC child in Canada News

Copyright © 2026 AHC International Media Library.

Powered by PressBook Masonry Dark